GlassScriptPhysician profile
Lora George
NPI 1740057835
$2,641.37
in general payments reported to CMS, 2019-2025
22 companies · $1,331 in 2025
The $1,331 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $16.84 · 2024: $1,294 · 2025: $1,331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,641.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $382.15 | 2024-2025 | Freestyle Libre 3 |
| Teva Pharmaceuticals USA, INC. | $259.98 | 2024-2025 | Austedo Xr |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $213.06 | 2024-2025 | Xifaxan |
| Amgen INC. | $207.21 | 2024-2025 | Krystexxa |
| Novo Nordisk INC | $178.56 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Globus Medical, INC. | $173.82 | 2025 | Senza |
| Inspire Medical Systems, INC. | $149.92 | 2024 | Inspire |
| Kerecis Limited | $145.70 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Insightec,INC | $133.27 | 2024 | Exablate |
| Phathom Pharmaceuticals, INC. | $121.77 | 2024 | Voquezna |
| Gilead Sciences, INC. | $118.33 | 2024 | Epclusa |
| Sanofi US Services INC. | $103.69 | 2025 | |
| Boston Scientific Corporation | $98.32 | 2025 | Eluvia |
| Phadia US INC. | $81.55 | 2025 | Immunocap |
| Smith+Nephew, INC. | $69.01 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $63.61 | 2025 | |
| Lilly USA, LLC | $34.46 | 2024 | Mounjaro |
| Abbvie INC. | $31.08 | 2024 | |
| Glaxosmithkline, LLC. | $22.49 | 2025 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.57 | 2024 | |
| Exact Sciences Corporation | $16.84 | 2023 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $14.98 | 2025 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lora George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.